NeuroBLOG

Part 5 — Photobiomodulation (PBM): The Layer 3 Modality I'm Not Ready For (Yet) *Brendan's Perspective* Key Points: • Photobiomodulation (PBM) — red and near-infrared light applied to tissue, including transcranially to the head — is the candid counterweight to the last piece in this series. Where taVNS earned a potential spot in my clinical toolbox by speaking directly to the autonomic and attentional systems neurofeedback already trains, PBM is a modality I want to take seriously enough to explain clearly why I am not integrating it… yet. The cellular mechanism is real. The transcranial clinical story is young, heterogeneous, and dogged by a problem most marketing pretends does not exist. • That problem is dosimetry. The therapeutic claim for transcranial PBM depends entirely on enough light of the right wavelength reaching enough cortical (or deeper) tissue to do something — and the scalp, skull, and meninges scatter and absorb the overwhelming majority of incident light before it gets there. A NeuroBLOG a while back walked through cadaver and modeling work suggesting that, for some consumer-grade systems, well over 99% of the emitted light never reaches the brain at all. The properly engineered research systems are a different conversation — and an expensive one. • The honest 2026 read: peripheral PBM (wound healing, musculoskeletal pain) has a respectable evidence base; transcranial PBM for brain targets is mechanistically intriguing, clinically early, and burned at least once already (the NEST stroke-laser program, which ended in a futility-stopped phase III). For a neurofeedback practice, the right posture is curious and patient — not dismissive, not an early adopter. Watch it; do not yet build on it.

*Brendan's Perspective* Key points: • A credential is a claim like any other, and it has a structure worth reading. The single most informative feature of that structure is whether the body issuing the credential is the same commercial entity that sells the required training, or a separate organisation that answers to a published standard rather than to enrolment numbers. • Independent certification keeps those roles apart by design. A separate body defines the competencies, sets the examination, holds the ethics code, and accepts candidates who trained with many different providers. International standards for certifying people treat that separation not as a courtesy but as a baseline requirement. • Proprietary credentialing collapses the roles into one. The credential may rest on genuinely excellent training — but its meaning is harder to read from outside, because the only body vouching for the graduate is the same body that was paid to produce the graduate. The aim here is not to disqualify either model. It is to teach you to read which one you are looking at.

Part 3 — Types of Neurofeedback series *Brendan's perspective* Key Points: • Strict bipolar protocols have a structural indeterminacy problem the field rarely names: from the bipolar signal alone, the practitioner cannot reconstruct what either of the underlying sites is doing. The brain is being asked to learn changes in a quantity whose underlying physiology no one in the room can read. • The modern alternative is to record two channels referentially and let the software derive the bipolar differential on the fly. You get both signals at once. Once that option is on the table, strict bipolar — differential only, no parallel referential record — has nothing left going for it. • There is a deeper limitation that matters clinically: a bipolar amplitude has no accessible felt correlate. Clients can learn to recognize and re-enter the state behind a single-site amplitude protocol; they cannot do the same for a difference between two sites. That makes bipolar protocols structurally weaker on what I have been calling neurofeedback's second active ingredient — conscious and voluntary self-regulation — and leaves them leaning on operant conditioning alone. There is one narrow population where the non-intuitiveness becomes a feature; Section 8 covers it.

Part 3 — Skin Conductance and Arousal Profiling in Clinical Practice *Brendan's Perspective* Key Points: • Skin conductance (SC) is the cleanest peripheral index of sympathetic arousal we have — a single-branch autonomic signal in a body otherwise full of multi-branch noise. Its clinical value in neurofeedback practice is less about training SC than about reading it: profiling who is hyperaroused, who is hypoaroused, and who is labile before the EEG protocol is selected. • The diagnostic information SC provides — tonic level, phasic response density, habituation slope — is information the EEG cannot give you cleanly on its own. Two clients with similar EEG profiles and very different SC profiles need different protocols, different sequencing, and sometimes different therapists. • For neurofeedback practitioners, SC is the natural pair to HRV biofeedback within the Layer 1 framework. Where HRV-BF is the substrate to train, SC is the substrate to read. One is the regulator. The other is the dashboard. Most NF setups have neither; the ones that ship faster, more durable outcomes tend to have both.

*Brendan's Perspective* Key points: • A clinical finding starts to look reliable when it has been replicated by teams that are independent of the people who developed the method. One trial — even a good one — is a beginning, not a conclusion. • Independence has two dimensions that the reader can check directly in published papers: independence of the investigators from the method's developers, and independence of the funding from commercial interests in the result. Both are legible in PubMed metadata if you know where to look. • The absence of independent replication is not a neutral fact. When a method has been in circulation for fifteen or twenty years and the literature still consists of studies run by the same network, that is a finding in itself — one that the phrase more research is needed tends to soften beyond recognition.

*Brendan's perspective* Key Points: • Neurofeedback is not a single method. It is a family of methods that share a common learning chassis — operant conditioning of brain activity through real-time feedback — but differ in what they measure, how localized that measurement is, how reproducibly the protocol can be described, and how mature their evidence base is. • "Which type of neurofeedback is best?" is the wrong question for clinicians. The better question is which type answers the clinical question I have in front of me, with infrastructure I can resource and supervision I can access? • This series unpacks eight core neurofeedback methods over the coming months — one per article — using a shared eight-section structure designed to make the methods genuinely comparable rather than rhetorically ranked.